Open original FDA record ↗Recall record
- FDA identifier
- Z-1622-2025
- Company in FDA record
- Maquet Cardiovascular, LLC
- FDA classification date
- Apr 18, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There have been at least 12 complaints from users as of March 3, 2025, reporting that they identified the ceramic C-Ring to be broken in half during use of the device. The ceramic C-Ring has a potential to break while in use. Maquet/Getinge determined that the issue was limited to the units of VH-4000 and VH-4001 manufactured with ceramic C-Ring, and the ceramic C-Ring was implemented in the Hemopro 2 devices from November 5, 2024, through February 14, 2025.
Source facts
- Action
- An URGENT MEDICAL DEVICE NOTIFICATION dated March 2025 was mailed to consignees. The notification provides instructions to users on how to proceed with a procedure if a ceramic C-Ring break occurs. If a consignee has a C-Ring break they are asked to save the device and complete the provided return form so Maquet Cardiovascular can conduct an investigation. Maquet instructs consignees to forward the notification to device users and to facilities to which product was further distributed for their awareness. Consignees are asked to return the provided response form by email to recallresponses.qrc@getinge.com. Questions can be directed to Maquet/Getinge Customer Support at 888-880-2874.
- Initiated
- 2025-03-20
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide and the countries of Mexico, United Arab Emirates, Singapore, India, Australia, Canada, Brazil, Hong Kong, Japan, South Korea, New Zealand.
- Recall number
- Z-1622-2025
- Recall status
- Open, Classified
- CDRH record ID
- 212876
- FDA classified
- 2025-04-18
- Recall event number
- 96439